241 related articles for article (PubMed ID: 12376518)
1. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.
Peshkin BN; Schwartz MD; Isaacs C; Hughes C; Main D; Lerman C
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1115-8. PubMed ID: 12376518
[TBL] [Abstract][Full Text] [Related]
2. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.
Botkin JR; Smith KR; Croyle RT; Baty BJ; Wylie JE; Dutson D; Chan A; Hamann HA; Lerman C; McDonald J; Venne V; Ward JH; Lyon E
Am J Med Genet A; 2003 Apr; 118A(3):201-9. PubMed ID: 12673648
[TBL] [Abstract][Full Text] [Related]
3. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
[TBL] [Abstract][Full Text] [Related]
4. Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.
Saadatmand S; Vos JR; Hooning MJ; Oosterwijk JC; Koppert LB; de Bock GH; Ausems MG; van Asperen CJ; Aalfs CM; Gómez Garcia EB; Meijers-Heijboer H; Hoogerbrugge N; Piek M; Seynaeve C; Verhoef C; Rookus M; Tilanus-Linthorst MM;
Int J Cancer; 2014 Dec; 135(12):2940-9. PubMed ID: 24789418
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
Lerman C; Hughes C; Croyle RT; Main D; Durham C; Snyder C; Bonney A; Lynch JF; Narod SA; Lynch HT
Prev Med; 2000 Jul; 31(1):75-80. PubMed ID: 10896846
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
[TBL] [Abstract][Full Text] [Related]
9. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?
Maheu C; Bouhnik AD; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Berthet P; Fricker JP; Caron O; Luporsi E; Gladieff L; Julian-Reynier C
Psychooncology; 2014 Apr; 23(4):420-7. PubMed ID: 24127257
[TBL] [Abstract][Full Text] [Related]
10. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA
Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
[TBL] [Abstract][Full Text] [Related]
12. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
Schwartz MD; Kaufman E; Peshkin BN; Isaacs C; Hughes C; DeMarco T; Finch C; Lerman C
J Clin Oncol; 2003 Nov; 21(21):4034-41. PubMed ID: 14581427
[TBL] [Abstract][Full Text] [Related]
13. Fertility intentions following testing for a BRCA1 gene mutation.
Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
[TBL] [Abstract][Full Text] [Related]
14. Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer.
Claes E; Evers-Kiebooms G; Decruyenaere M; Denayer L; Boogaerts A; Philippe K; Legius E
Behav Med; 2005; 31(3):93-105. PubMed ID: 16252621
[TBL] [Abstract][Full Text] [Related]
15. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.
Calderon-Margalit R; Paltiel O
Int J Cancer; 2004 Nov; 112(3):357-64. PubMed ID: 15382059
[TBL] [Abstract][Full Text] [Related]
16. Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Phillips KA; Jenkins MA; Lindeman GJ; McLachlan SA; McKinley JM; Weideman PC; Hopper JL; Friedlander ML;
Clin Genet; 2006 Sep; 70(3):198-206. PubMed ID: 16922722
[TBL] [Abstract][Full Text] [Related]
17. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.
Halbert CH; Wenzel L; Lerman C; Peshkin BN; Narod S; Marcus A; Corio C; Demarco T; Bellamy S
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):875-81. PubMed ID: 15159322
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.
Dawson SJ; Price MA; Jenkins MA; McKinley JM; Butow PN; McLachlan SA; Lindeman GJ; Weideman P; Friedlander ML; Hopper JL; Phillips KA
J Clin Oncol; 2008 Jan; 26(2):225-32. PubMed ID: 18040054
[TBL] [Abstract][Full Text] [Related]
19. Predictors of breast cancer screening behavior in women with a strong family history of the disease.
Price MA; Butow PN; Charles M; Bullen T; Meiser B; McKinley JM; McLachlan SA; Phillips KA; ;
Breast Cancer Res Treat; 2010 Nov; 124(2):509-19. PubMed ID: 20364401
[TBL] [Abstract][Full Text] [Related]
20. Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing?
Larouche G; Chiquette J; Pelletier S; Simard J; Dorval M
Fam Cancer; 2017 Jan; 16(1):35-40. PubMed ID: 27554086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
